Peptide-based delivery system used for tagging Syk Tyrosine Kinase biomarker in skin cancer and development of a hyperspectral imaging device to detect the biomarker

被引：0

作者：

Galligan, Bri ^{[1
]}

Riling, Ryan ^{[1
]}

Stufflet, Jessica ^{[1
]}

Swarup, Aparna ^{[1
]}

Sunkari, Chetana ^{[1
]}

Alfego, David ^{[1
]}

Kriete, Andres ^{[1
]}

机构：

[1] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA

来源：

2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013) | 2013年

关键词：

Spleen Tyrosine Kinase (Syk); liposomes; hyperspectral imaging; skin cancer; syk peptide;

D O I：

10.1109/NEBEC.2013.125

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

We propose to design a non-invasive diagnostic method for the early detection of SCC and BCC using a hyperspectral imaging device that will detect fluorescence. The technique used to deliver the fluorescent tag will be in the form of a topical formulation consisting of a Syk-specific peptide conjugated to a fluorescent dye encapsulated in liposomes.

引用

页码：143 / 144

页数：2

共 3 条

[1] Development of a peptide-based lateral flow assay for the detection of the cancer biomarker Mdm2
Gosselin, Bryan
Retout, Maurice
Jabin, Ivan
Bruylants, Gilles
SENSORS & DIAGNOSTICS, 2024, 3 (02): : 248 - 255
[2] Development of novel cancer cell-selective cell-penetrating peptides for the advanced peptide-based drug delivery system
Kondo, E.
EJC SUPPLEMENTS, 2010, 8 (07): : 135 - 135
[3] PET Imaging-Based Phenotyping as a Predictive Biomarker of Response to Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer: Are We There Yet?
Gerbaudo V.H.
Kim C.K.
Nuclear Medicine and Molecular Imaging, 2017, 51 (1) : 3 - 10

← 1 →